Source: Eur Respir J 2014; 44: 178-187
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Silhan Leann L., Shah Pali D., Chambers Daniel C., Snyder Laurie D., Riise Gerdt C., Wagner Christa L., Hellström-Lindberg Eva, Orens Jonathan B., Mewton Juliette F., Danoff Sonye K., Arcasoy Murat O., Armanios Mary. Lung transplantation in telomerase mutation carriers with pulmonary fibrosis. Eur Respir J 2014; 44: 178-187

Member's Comments

No comment yet.

Related content which might interest you: Lung transplantation for pulmonary fibrosis Source: International Congress 2015 – Lung transplantation in the year 2015: current indications and results Year: 2015 Lung function tests and survival in idiopathic pulmonary fibrosis after lung transplantation Source: Eur Respir J 2005; 26: Suppl. 49, 335s Year: 2005 Clinical outcomes after lung transplantation for fibrosis in telomerase related genes mutation carriers Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes Year: 2019 Lung transplantation in idiopathic pulmonary fibrosis Source: International Congress 2016 – Russia Session Year: 2016 Survival and lung function in double lung transplant recipients with cystic fibrosis Source: International Congress 2017 – From donor lung selection and organ preservation to lung transplant outcome Year: 2017 Lung transplantation for cystic fibrosis Source: Eur Respir Monogr 2014; 64: 236-245 Year: 2014 Lung transplantation for cystic fibrosis Source: International Congress 2015 – Lung transplantation in the year 2015: current indications and results Year: 2015 Cystic fibrosis lung disease and lung transplantation Source: ERS Skills Course 2016 Year: 2016 Lung function in children with cystic fibrosis liver disease Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 The effect of pirfenidone on impaired lung function in patients with idiopathic pulmonary fibrosis (IPF) from Czech IPF registry Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Pulmonary alveolar proteinosis due to heterozygous mutation in OAS1: Treatment of a novel disease with whole lung lavages and stem cell transplantation Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans Year: 2019 Total lung capacity size matching in fibrosis lung transplantation Source: International Congress 2016 – Long-term outcomes of lung transplantation Year: 2016 Clinical characteristics and pulmonary function in patients with pulmonary fibrosis assessed for lung transplant Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation Year: 2010 Exercise capacity following lung transplantation in cystic fibrosis patients Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous Year: 2008 Lung function and disease severity in cystic fibrosis patients heterozygous for p.Arg117His Source: ERJ Open Res, 3 (1) 00056-2016; 10.1183/23120541.00056-2016 Year: 2017 Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 347s Year: 2002 CF lung disease and lung transplantation Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine Year: 2017 CF lung disease and lung transplantation Source: ERS Course 2018 - Summer school of paediatric respiratory medicine Year: 2018 CF lung disease and lung transplantation Source: ERS Course 2019 - Summer school of paediatric respiratory medicine 2019 Year: 2019 New approach to the treatment of bleomycin-induced lung fibrosis using pulmonary surfactant as pirfenidone carrier into the lung Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015